TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.7795
+0.0033 (0.43%)
At close: Aug 21, 2026, 4:00 PM EDT
0.7774
-0.0021 (-0.27%)
After-hours: Aug 21, 2026, 7:30 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $52.83 million as of August 21, 2026. Its market cap has decreased by -45.23% in one year.
Market Cap
52.83M
Enterprise Value
43.57M
1-Year Change
-45.23%
Ranking
Category
Stock Price
$0.78
ChartMarket Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $52.83M, a decrease of -85.29%. That is a compound annual growth rate of -31.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 52.83M | -6.90% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 55.39M |
| Immutep | 53.51M |
| aTyr Pharma | 52.26M |
| Apollomics | 51.80M |
| Instil Bio | 50.12M |
| Mereo BioPharma Group | 49.74M |
| Hyperion DeFi | 47.24M |
| Veraxa Biotech AG | 46.90M |